These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 20135628)

  • 21. VMAT2 Inhibitors and the Path to Ingrezza (Valbenazine).
    Harriott ND; Williams JP; Smith EB; Bozigian HP; Grigoriadis DE
    Prog Med Chem; 2018; 57(1):87-111. PubMed ID: 29680151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase A affects trafficking of the vesicular monoamine transporters in PC12 cells.
    Yao J; Erickson JD; Hersh LB
    Traffic; 2004 Dec; 5(12):1006-16. PubMed ID: 15522101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vesicular monoamine transporters expression in pheochromocytomas and paragangliomas according to scintigraphy and positron emission tomography behavior.
    Bacca A; Pucci A; Lorenzini D; Chiacchio S; Volterrani D; Ferrari M; Sellari Franceschini S; Materazzi G; Basolo F; Bernini G
    Q J Nucl Med Mol Imaging; 2021 Dec; 65(4):396-401. PubMed ID: 35133098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The first luminal domain of vesicular monoamine transporters mediates G-protein-dependent regulation of transmitter uptake.
    Brunk I; Blex C; Rachakonda S; Höltje M; Winter S; Pahner I; Walther DJ; Ahnert-Hilger G
    J Biol Chem; 2006 Nov; 281(44):33373-85. PubMed ID: 16926160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.
    Guillot TS; Miller GW
    Mol Neurobiol; 2009 Apr; 39(2):149-70. PubMed ID: 19259829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of a vesicular monoamine transporter by casein kinase II.
    Krantz DE; Peter D; Liu Y; Edwards RH
    J Biol Chem; 1997 Mar; 272(10):6752-9. PubMed ID: 9045708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neuronal monoamine transporter VMAT2 is regulated by the trimeric GTPase Go(2).
    Höltje M; von Jagow B; Pahner I; Lautenschlager M; Hörtnagl H; Nürnberg B; Jahn R; Ahnert-Hilger G
    J Neurosci; 2000 Mar; 20(6):2131-41. PubMed ID: 10704487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors.
    Duerr JS; Frisby DL; Gaskin J; Duke A; Asermely K; Huddleston D; Eiden LE; Rand JB
    J Neurosci; 1999 Jan; 19(1):72-84. PubMed ID: 9870940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. II. Expression in neural crest derivatives and their target sites in the rat.
    Hansson SR; Mezey E; Hoffman BJ
    Brain Res Dev Brain Res; 1998 Sep; 110(1):159-74. PubMed ID: 9733958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in the expression of catecholamine-synthesizing enzymes between vesicular monoamine transporter 1- and 2-immunoreactive glomus cells in the rat carotid body.
    Kato K; Yokoyama T; Kusakabe T; Hata K; Fushuku S; Nakamuta N; Yamamoto Y
    Acta Histochem; 2020 Apr; 122(3):151507. PubMed ID: 31955909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei.
    Nirenberg MJ; Liu Y; Peter D; Edwards RH; Pickel VM
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8773-7. PubMed ID: 7568015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder.
    Lohoff FW; Dahl JP; Ferraro TN; Arnold SE; Gallinat J; Sander T; Berrettini WH
    Neuropsychopharmacology; 2006 Dec; 31(12):2739-47. PubMed ID: 16936705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human-specific mutations in VMAT1 confer functional changes and multi-directional evolution in the regulation of monoamine circuits.
    Sato DX; Ishii Y; Nagai T; Ohashi K; Kawata M
    BMC Evol Biol; 2019 Dec; 19(1):220. PubMed ID: 31791232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deutetrabenazine for the treatment of Huntington's chorea.
    Bashir H; Jankovic J
    Expert Rev Neurother; 2018 Aug; 18(8):625-631. PubMed ID: 29996061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyrrolidine analogues of lobelane: relationship of affinity for the dihydrotetrabenazine binding site with function of the vesicular monoamine transporter 2 (VMAT2).
    Vartak AP; Nickell JR; Chagkutip J; Dwoskin LP; Crooks PA
    J Med Chem; 2009 Dec; 52(23):7878-82. PubMed ID: 19691331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter.
    Provencher BA; Eshleman AJ; Johnson RA; Shi X; Kryatova O; Nelson J; Tian J; Gonzalez M; Meltzer PC; Janowsky A
    J Med Chem; 2018 Oct; 61(20):9121-9131. PubMed ID: 30240563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.
    Crooks PA; Zheng G; Vartak AP; Culver JP; Zheng F; Horton DB; Dwoskin LP
    Curr Top Med Chem; 2011; 11(9):1103-27. PubMed ID: 21050177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of vesicular monoamine transporters in endocrine hyperplasia and endocrine tumors of the oxyntic stomach.
    Eissele R; Anlauf M; Schäfer MK; Eiden LE; Arnold R; Weihe E
    Digestion; 1999; 60(5):428-39. PubMed ID: 10473967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis.
    Anlauf M; Schäfer MK; Schwark T; von Wurmb-Schwark N; Brand V; Sipos B; Horny HP; Parwaresch R; Hartschuh W; Eiden LE; Klöppel G; Weihe E
    J Histochem Cytochem; 2006 Feb; 54(2):201-13. PubMed ID: 16116033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands.
    Zheng P; Lieberman BP; Choi SR; Plöessl K; Kung HF
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3435-8. PubMed ID: 21531556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.